Intravitreal ranibizumab (IVR) has been found to improve vision related quality of life in diabetic macular oedema (DME) patients, notes a study recently published in the Journal of Diabetes and Its Complications.
PRK has been an established method for laser vision correction for nearly 30 years, however, its popularity has reduced somewhat due to the advent of LASIK. With a recent renewed interest in surface ablation techniques some modifications have been made to alleviate disadvantages of the procedure. In this article, the authors highlight their clinical experience of TESA in myopic eyes with or without astigmatism.
Patients who used a proprietary eye drop delivery device (Eyedrop, Vanguard Design, São Paulo, Brazil) in a pilot study reported that it eased the instillation of hypotensive drops, especially if they weren’t used to using eye drops, the study authors report in the Journal of Clinical Ophthalmology.
Biodegradable nanoparticles that release medication into the eye may solve the issue of medicine compliance after corneal transplant surgery and help increase the rate of surgical success, according to an article in the Journal of Controlled Release.
A proprietary radiotherapy system (IRay, Oraya Therapeutics) used to treat exudative age-related macular degeneration (AMD) now also may be used to treat choroidal metastases following a CE mark extension.
Visual function improves in eyes with age-related macular degeneration (AMD) that have undergone cataract surgery, but the extent of the improvement depends on the eye’s preoperative best-corrected visual acuity (preBCVA), according to a new retrospective analysis published in Investigative Ophthalmology and Visual Science.
Implandata Ophthalmic Products GmbH (Implandata) says it has successfully implanted its EyeMate intraocular pressure (IOP) sensor implant in a first patient in Europe undergoing keratoprosthesis surgery.
In a 1-year comparison of intravitreous aflibercept, bevacizumab and ranibizumab therapy for centre-involved DME, aflibercept was more effective at improving vision among patients who started treatment at lower levels of visual acuity.